Fructose-6-phosphate aldolase (FSA) (FSA)

Fructose-6-phosphate aldolase (FSA) is a Class I aldolase enzyme, primarily characterized in Escherichia coli, that catalyzes the reversible aldol addition of dihydroxyacetone to various aldehydes [1, 2]. It is distinguished from other aldolases by its ability to accept non-phosphorylated substrates, which has made it a highly valuable tool in biocatalysis and the synthesis of rare sugars and iminocyclitols [3]. In its natural biological context, FSA is involved in the non-oxidative pentose phosphate pathway, facilitating the interconversion of sugars to maintain metabolic flux [2]. Although it is an essential metabolic enzyme in certain bacteria, it is not currently recognized as a therapeutic target for human medicine, nor are there any clinical drugs designed to inhibit or activate it [1]. Its industrial importance stems from its high stereoselectivity and stability, allowing for the efficient production of complex polyhydroxylated compounds [3]. The enzyme exists in two isoforms in E. coli, FsaA and FsaB, which share significant sequence identity and catalytic properties [1, 2]. Research into FSA continues to expand its substrate scope for the synthesis of diverse carbohydrate derivatives, highlighting its role as a versatile biocatalyst rather than a disease-related protein [3].

Other names

FSAFsaAFsaBD-fructose-6-phosphate aldolase

Fructose-6-phosphate aldolase operates via a Class I aldolase mechanism, involving the formation of a covalent Schiff base intermediate between a conserved lysine residue in the active site and the carbonyl group of the donor substrate, typically dihydroxyacetone [1, 2].